The Trump administration sent letters this summer to 17 makers of name-brand drugs pushing them to lower prices to align them with what other countries pay. The companies had 60 days to "step up."
Continue Reading on NPR
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.